tm
Seeing Is Believing
tm
Seeing Is Believing
SMMT is currently covered by 11 analysts with an average price target of $30.46. This is a potential upside of $13.19 (76.38%) from yesterday's end of day stock price of $17.27.
Summit Therapeutics PLC's activity chart (see below) currently has 78 price targets and 93 ratings on display. The stock rating distribution of SMMT is 60.71% BUY, 17.86% SELL and 21.43% HOLD.
Analysts average stock forecasts to be materialized ratio is 51.3% with an average time for these price targets to be met of 223.25 days.
Highest price target for SMMT is $43, Lowest price target is $13, average price target is $30.46.
Most recent stock forecast was given by ETZER DAROUT from BARCLAYS. First documented stock forecast 04-Jan-2018.
Currently out of the existing stock ratings of SMMT, 17 are a BUY (60.71%), 5 are a SELL (17.86%), 6 are a HOLD (21.43%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-Oct-2026
$20
$3.24 (19.33%)
$18
Buy Since 20-Oct-2025
$43
$26.24 (156.56%)
$131.9
Hold Since 23-Jul-2026
12 days ago
(23-Sep-2026)
4/24 (16.67%)
$6.02 (35.45%)
15
Sell Since 11-Jun-2025
$13
$-3.76 (-22.43%)
$12
1 months 23 days ago
(12-Aug-2026)
1/2 (50%)
$-2.1 (-13.91%)
5
Buy Since 04-Sep-2025
$38
$21.24 (126.73%)
$40
2 months 11 days ago
(24-Jul-2026)
3/9 (33.33%)
$24.34 (178.18%)
56
What is SMMT (Summit Therapeutics PLC) average time for price targets to be met?
Which analyst most recently updated their price target on SMMT (Summit Therapeutics PLC)?
Which analyst has the most public recommendations on SMMT (Summit Therapeutics PLC)?
Which analyst is the currently most bullish on SMMT (Summit Therapeutics PLC)?
Which analyst is the currently most reserved on SMMT (Summit Therapeutics PLC)?
